Literature DB >> 11442763

Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides.

H Hegyesi1, B Somlai, V L Varga, G Toth, P Kovacs, E L Molnar, V Laszlo, S Karpati, E Rivera, A Falus, Z Darvas.   

Abstract

Histidine decarboxylase (HDC) is expressed by the cells of melanoma, in which the histamine content tends to be relatively high. This study shows that elevated expression of HDC was found by western blot analysis of primary and metastatic melanoma tissue using a polyclonal HDC specific antibody. The specificity of anti-HDC antibody was confirmed by inhibition of HDC translation (i.e., immunopositivity) in melanoma cells by HDC-specific antisense oligonucleotide. Moreover, the decrease in proliferation caused by HDC antisense oligonucleotides indicates considerable functional relevance of histamine synthesis in melanoma growth and suggests a possible in situ application of specific antisense oligonucleotides for HDC in melanoma therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442763     DOI: 10.1046/j.0022-202x.2001.01406.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

1.  Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer.

Authors:  Woo Hyun Paik; Ji Kon Ryu; Kyoung-Sin Jeong; Jin Myung Park; Byeong Jun Song; Sang Hyub Lee; Yong-Tae Kim; Yong Bum Yoon
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Histamine regulates growth of malignant melanoma implants via H2 receptors in mice.

Authors:  Kazuyoshi Tomita; Eiji Nakamura; Susumu Okabe
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 3.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

4.  Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma.

Authors:  Nabil M Abdel-Hamid; Amer Hasan Abdullah
Journal:  Clin Exp Med       Date:  2018-11-20       Impact factor: 3.984

5.  Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma.

Authors:  Martin Grimm; Michael Krimmel; Dorothea Alexander; Adelheid Munz; Susanne Kluba; Constanze Keutel; Juergen Hoffmann; Joachim Polligkeit; Siegmar Reinert; Sebastian Hoefert
Journal:  Clin Oral Investig       Date:  2012-07-11       Impact factor: 3.573

Review 6.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 7.  Mast cells: an expanding pathophysiological role from allergy to other disorders.

Authors:  Preet Anand; Baldev Singh; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-06       Impact factor: 3.000

8.  Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.

Authors:  Yi Wang; Yang Jiang; Jun-Ichiro Ikeda; Tian Tian; Atsushi Sato; Hiroshi Ohtsu; Eiichi Morii
Journal:  Cancer Med       Date:  2014-07-10       Impact factor: 4.452

9.  Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.

Authors:  Noelia A Massari; Melisa B Nicoud; Lorena Sambuco; Graciela P Cricco; Diego J Martinel Lamas; María V Herrero Ducloux; Horacio Blanco; Elena S Rivera; Vanina A Medina
Journal:  Oncotarget       Date:  2017-04-18

10.  Combinatory Effects of Cerium Dioxide Nanoparticles and Acetaminophen on the Liver-A Case Study of Low-Dose Interactions in Human HuH-7 Cells.

Authors:  Benjamin C Krause; Fabian L Kriegel; Victoria Tartz; Harald Jungnickel; Philipp Reichardt; Ajay Vikram Singh; Peter Laux; Mohamed Shemis; Andreas Luch
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.